Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Small

Showing results (101-110 of 361) with videos related to

Pageof 37
Sort By:
Clinical Genitourinary Cancer|May 3, 2014
Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatmentRahul Aggarwal, Anna Harris, Carl Formaker, et al.
Cancer|June 29, 2004
Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinomaBrian I Rini, Vivian Weinberg, Vanessa Shaw, et al.
Nature Reviews. Drug Discovery|July 2, 2010
Sipuleucel-TCelestia S Higano, Eric J Small, Paul Schellhammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
Reply to A. Dalla Volta et alRahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
American Journal of Clinical Oncology|April 2, 2005
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancerUzair B Chaudhary, Lloyd E Damon, Hope S Rugo, et al.
BJU International|April 5, 2007
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancerJorge A Garcia, Jonathan E Rosenberg, Vivian Weinberg, et al.
Clinical Nuclear Medicine|November 6, 2018
Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary MetastasesPaola M Perez, Thomas A Hope, Spencer C Behr, et al.
Cancer|December 22, 2005
Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Sarah Dunlap, et al.
Clinical Prostate Cancer|May 11, 2005
Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancerSara K Sheriff, Ryo A Shohara, Sarah B Dumican, et al.
Urologic Oncology|June 24, 2022
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked datasetDaniel H Kwon, Alan Paciorek, Li Zhang, et al.
Pageof 37

Showing results (101-110 of 361) with videos related to

Sort By:
Pageof 37
Clinical Genitourinary Cancer|May 3, 2014
Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatmentRahul Aggarwal, Anna Harris, Carl Formaker, et al.
Cancer|June 29, 2004
Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinomaBrian I Rini, Vivian Weinberg, Vanessa Shaw, et al.
Nature Reviews. Drug Discovery|July 2, 2010
Sipuleucel-TCelestia S Higano, Eric J Small, Paul Schellhammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2018
Reply to A. Dalla Volta et alRahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
American Journal of Clinical Oncology|April 2, 2005
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancerUzair B Chaudhary, Lloyd E Damon, Hope S Rugo, et al.
BJU International|April 5, 2007
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancerJorge A Garcia, Jonathan E Rosenberg, Vivian Weinberg, et al.
Clinical Nuclear Medicine|November 6, 2018
Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary MetastasesPaola M Perez, Thomas A Hope, Spencer C Behr, et al.
Cancer|December 22, 2005
Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Sarah Dunlap, et al.
Clinical Prostate Cancer|May 11, 2005
Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancerSara K Sheriff, Ryo A Shohara, Sarah B Dumican, et al.
Urologic Oncology|June 24, 2022
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked datasetDaniel H Kwon, Alan Paciorek, Li Zhang, et al.
Pageof 37